secwatch.observer — SEC 8-K summary
======================================

Issuer:     Passage BIO, Inc. (PASG)
CIK:        0001787297
Form:       8-K
Filed at:   2022-03-11T23:59:59+00:00
Accession:  0001104659-22-032947
Event type: leadership
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Passage Bio director Liam Ratcliffe resigns over disagreement on business plans
-------------------------------------------------------------------------------

- Liam Ratcliffe, MD, Ph.D., resigned from the Board and its Nominating and Governance Committee, effective March 7, 2022.
- Resignation cited a disagreement with the company regarding its business plans and operations.
- No replacement announced; Board size reduced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787297/000110465922032947/0001104659-22-032947-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787297/000110465922032947/tm228940d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-032947

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer